Artificial intelligence (AI) in cancer care has the potential to transform nursing practice, reduce cancer disparities, and enhance patient outcomes across the continuum of care from prevention, screening, and treatment to su.
Artificial intelligence (AI) in cancer care has the potential to transform nursing practice, reduce cancer disparities, and enhance patient outcomes across the continuum of care from prevention, screening, and treatment to su.
Background: Implanted ports are essential for long-term vascular access. However, port occlusions can lead to treatment delays and reduced quality of life. Concerns about the safety of heparin have led to the exploration of safer alternatives.
Objectives: This study aimed to assess the effectiveness of 20 ml normal saline using the push-pause flush technique, compared to heparin, in preventing implanted port occlusions.
Methods: A cohort study of 538 patients with implanted ports was conducted over five months. Data on demographics, port type, locking solution, occlusions, and interventions were collected. A transition from heparin-based flushing to normal saline-based flushing occurred during the study.
Findings: Preliminary analysis showed low overall port occlusion rates, regardless of the locking solution used. A Fisher's exact test revealed no significant association between the type of locking solution and port occlusion. Interim findings suggest that when used with the pulsatile flush technique, normal saline may be as effective as heparin in maintaining port patency. Additional research is needed to assess the long-term implications of using saline as a locking solution.
Oncology nurses working at a rural community infusion clinic observed an increase in infusion-related reactions while administering the first and second treatments of liposomal doxorubicin. Review of the package insert reveal.
CJON has maintained editorial and scholarly integrity, with a commitment to publication ethics, across three decades. CJON has educated readers about the impact of ghostwritten manuscripts, authorship criteria, and embedded a.
To commemorate ONS's 50th anniversary in 2025, throughout the year, we will be reprinting seminal editorials written by former editors of the Oncology Nursing Forum and the Clinical Journal of Oncology Nursing that have.
This review examines current clinical practice guidelines and recommendations for lymphedema, focusing on the essential components of a prospective surveillance program. It synthesizes evidence-based practices recommended by.
Lung cancer is the leading cause of cancer-related deaths worldwide, yet early diagnosis is often missed in most individuals. Early screening is conducted via low-dose computed tomography (LDCT), particularly for those who ar.
Background: The addition of blinatumomab to chemotherapy is the new standard of care for most pediatric patients with B-lineage acute lymphoblastic leukemia (B-ALL), and its use has increased rapidly. Administering blinatumomab to pediatric patients is associated with a spectrum of unique challenges, resulting in variable practices across institutions.
Objectives: This article presents expert recommendations for blinatumomab administration in patients with pediatric B-ALL.
Methods: Pediatric oncology nurses, physicians, and pharmacists collated current evidence and Children's Oncology Group institutional experiences to identify considerations for planning for blinatumomab administration, initiating and managing infusions, and monitoring for adverse events.
Findings: Engaging patients, families, and clinicians promotes care transitions between inpatient and outpatient settings and minimizes complications. Ongoing institutional commitment to monitor and capture emerging trends in blinatumomab administration can inform future optimal care practices.
When I began as a nurse, there were no targeted agents; no granulocyte-colony-stimulating factors; no sophisticated antibiotics, antivirals, or antifungals; and no electronic health records. Palliative care and survivorship.
Background: Chemotherapy can contribute to chemotherapy-induced nausea and vomiting (CINV). The use of acupressure is a nonpharmacologic method to counteract general nausea and vomiting.
Objectives: The primary end point was to determine whether there were any differences in CINV episodes between patients receiving acupressure at two different acupressure points.
Methods: Patients (N = 509) were randomized between acupressure at the Pericardium 6 point and the Triple Warmer 5 point. Patients reported data in a structured diary for 10 days and health-related quality of life using a questionnaire on days 1 and 10.
Findings: Regardless of group, 70 patients reported having decreased global health status after the first chemotherapy treatment. There was no difference in the occurrence or intensity of CINV between acupressure applied at the two different points. Antiemetic prophylaxis remains the most important method of counteracting CINV.

